Yves Allory

Yves Allory

UNVERIFIED PROFILE

Are you Yves Allory?   Register this Author

Register author
Yves Allory

Yves Allory

Publications by authors named "Yves Allory"

Are you Yves Allory?   Register this Author

100Publications

3029Reads

41Profile Views

Progenitors from the central nervous system drive neurogenesis in cancer.

Nature 2019 May 15;569(7758):672-678. Epub 2019 May 15.

UMR967 (Laboratoire Cancer et Microenvironnement ATIP/AVENIR-INSERM-CEA), Institut de Radiobiologie Cellulaire et Moléculaire, Institut de Biologie François Jacob, Direction de la Recherche Fondamentale, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41586-019-1219-yDOI Listing
May 2019

[Testicular germ cell tumors: Histopathological and molecular features].

Bull Cancer 2019 Apr 21;106(4):328-341. Epub 2019 Mar 21.

Hôpital Foch, service d'anatomie et cytologie pathologiques, 40, rue Worth, 92150 Suresnes, France; Institut Curie, service de pathologie, 35, rue Dailly, 92240 Saint Cloud, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.02.004DOI Listing
April 2019

Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.

Eur J Cancer 2019 Feb 14;108:111-119. Epub 2019 Jan 14.

Department of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.12.010DOI Listing
February 2019

Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment.

Semin Cancer Biol 2018 10 12;52(Pt 2):216-227. Epub 2017 Oct 12.

Department of Pathology, University Clinics St Luc, Sint-Lambrechts-Woluwe, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.10.004DOI Listing
October 2018

Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibility.

Mod Pathol 2018 08 21;31(8):1270-1281. Epub 2018 Feb 21.

Département Hospitalo-Universitaire (DHU), Virus-Immunité-Cancer (VIC), Université Paris-Est-Créteil, (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), Equipe 7 Translational Research of Genito-Urinary Oncogenesis, INSERM U 955, Créteil, F-94010, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0023-9DOI Listing
August 2018

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization.

Transl Androl Urol 2018 Aug;7(4):757-759

Department of Urology, Centre Hospitalier Universitaire, Rouen University, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2018.06.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127548PMC
August 2018

Predictive factors for final pathologic ureteral sections on 700 radical cystectomy specimens: Implications for intraoperative frozen section decision-making.

Urol Oncol 2017 11 14;35(11):659.e1-659.e6. Epub 2017 Jul 14.

Department of Urology and Transplantation, Picardie Jules Verne University, CHU Amiens, Amiens, France; HeRVI EA 3801, Picardie Jules Verne University, CHU Amiens, Amiens, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439173033
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2017.06.053DOI Listing
November 2017

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Nov;24(6):311-335

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638696PMC
November 2017

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.

Virchows Arch 2017 Oct 15;471(4):491-500. Epub 2017 Aug 15.

AP-HP, Groupe Hospitalier Paris-Centre, hôpital Cochin, 75014, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2213-0DOI Listing
October 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Sep;24(5):235-251

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564448PMC
September 2017

Renal Medullary Carcinoma: Establishing Standards in Practice.

J Oncol Pract 2017 07;13(7):414-421

Vanderbilt University Medical Center, Nashville; St Jude Children's Research Hospital, Memphis, TN; University of Texas MD Anderson Cancer Center; Baylor College of Medicine, Houston, TX; American University of Beirut Medical Center, Beirut, Lebanon; Université Paris-Est Créteil, Créteil; Institut Curie; University Pierre and Marie Curie, Paris, France; University of North Carolina at Chapel Hill, Chapel Hill, NC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; Johns Hopkins University, Baltimore, MD; Memorial Sloan Kettering Cancer Center, New York, NY; and University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.020909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508447PMC
July 2017

Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.

J Proteome Res 2017 04 23;16(4):1617-1631. Epub 2017 Mar 23.

Genomics and Proteomics Research Unit, Department of Oncology, Luxembourg Institute of Health , 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.6b00979DOI Listing
April 2017

[Immunotherapy in uropathology].

Ann Pathol 2017 Feb 19;37(1):90-100. Epub 2017 Jan 19.

Service d'anatomie pathologique, hôpital Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94000 Créteil, France; Faculté de médecine, université Paris-Est Créteil Val de Marne (UPEC), 61, avenue du Général-de-Gaulle, 94000 Créteil, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02426498163018
Publisher Site
http://dx.doi.org/10.1016/j.annpat.2016.12.015DOI Listing
February 2017

[Bladder tumor histo-seminar - pre-test].

Authors:
Yves Allory

Ann Pathol 2016 Dec 9;36(6):373-374. Epub 2016 Nov 9.

Département de pathologie, hôpital Henri-Mondor, AP-HP, 51, avenue Mal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.09.013DOI Listing
December 2016

[Bladder tumor histo-seminar - case 6: Invasive urothelial carcinoma, with inverted growth (UroA/FGFR3 molecular type)].

Authors:
Yves Allory

Ann Pathol 2016 Dec 9;36(6):394-397. Epub 2016 Nov 9.

Département de pathologie, hôpital Henri-Mondor, AP-HP, 51, avenue Mal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02426498163012
Publisher Site
http://dx.doi.org/10.1016/j.annpat.2016.09.010DOI Listing
December 2016

[Bladder tumor histo-seminar - case 5: Urothelial carcinoma with squamous differentiation (basal type)].

Authors:
Yves Allory

Ann Pathol 2016 Dec 9;36(6):390-393. Epub 2016 Nov 9.

Département de pathologie, hôpital Henri-Mondor, AP-HP, 51, avenue Mal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.09.014DOI Listing
December 2016

[Bladder tumor histo-seminar - pre-test answers].

Authors:
Yves Allory

Ann Pathol 2016 Dec 9;36(6):410-411. Epub 2016 Nov 9.

Département de pathologie, hôpital Henri-Mondor, AP-HP, 51, avenue Mal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.09.009DOI Listing
December 2016

[Bladder tumor histoseminar - Introduction. Bladder tumours diagnosis facing new treatments and new molecular classifications].

Authors:
Yves Allory

Ann Pathol 2016 Dec 9;36(6):371-372. Epub 2016 Nov 9.

Département de pathologie, hôpital Henri-Mondor, AP-HP, 51, avenue Mal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02426498163012
Publisher Site
http://dx.doi.org/10.1016/j.annpat.2016.09.012DOI Listing
December 2016

A prospective multicenter study on bladder cancer: the COBLAnCE cohort.

BMC Cancer 2016 11 3;16(1):837. Epub 2016 Nov 3.

Service d'urologie et de transplantation rénale, Hôpital Foch, Suresnes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2877-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094141PMC
November 2016

Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas.

Eur Urol 2016 06 1;69(6):1055-61. Epub 2015 Oct 1.

INSERM U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France; SiRIC Institut Curie, Recherche Translationnelle en Oncologie Pediatrique, Paris, France; Institut Curie, Département d'Oncologie Pédiatrique -Adolescents Jeunes Adultes, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.09.027DOI Listing
June 2016

Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5.

Eur J Cancer 2015 Oct 26;51(15):2217-2230. Epub 2015 Sep 26.

Analytical Epidemiology and Health Impact Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.07.028DOI Listing
October 2015

Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores.

World J Urol 2015 Jun 2;33(6):787-92. Epub 2014 Jul 2.

Academic Department of Urology of Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris, 51 Avenue Du Maréchal de Lattre de Tassigny, 94000, Créteil, France,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00345-014-1348
Web Search
http://link.springer.com/10.1007/s00345-014-1348-8
Publisher Site
http://dx.doi.org/10.1007/s00345-014-1348-8DOI Listing
June 2015

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.

Cancer 2015 May 13;121(9):1422-30. Epub 2015 Jan 13.

INSERM Unit 955, Creteil, France; Research Unit UMRS955, University of Paris-Est, Creteil, France; CNRS UMR 3244, Institut Curie, Paris, France; INSERM Unit 753, Institut Gustave-Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29233DOI Listing
May 2015

Inflammatory biomarkers and bladder cancer prognosis: a systematic review.

Eur Urol 2014 Dec 20;66(6):1078-91. Epub 2014 Aug 20.

Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.07.033DOI Listing
December 2014

[Classification and natural history of bladder tumors].

Authors:
Yves Allory

Rev Prat 2014 Dec;64(10):1365-6, 1368-71

View Article

Download full-text PDF

Source
December 2014

Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes.

Cell Rep 2014 Nov 13;9(4):1235-45. Epub 2014 Nov 13.

Institut Curie, Centre de Recherche, 75248 cedex 05 Paris, France; CNRS, UMR 144, Oncologie Moléculaire, Equipe Labellisée Ligue Contre le Cancer, Institut Curie, 75248 cedex 05 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.10.035DOI Listing
November 2014

DNA comparison between operative and biopsy specimens to investigate stage pT0 after radical prostatectomy.

World J Urol 2014 Aug 27;32(4):899-904. Epub 2014 Mar 27.

Department of Urology, Paris Sud University Hospital of Bicetre, 94270, Le Kremlin Bicetre, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-014-1278-5DOI Listing
August 2014

Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses.

Proteomics 2014 Jun 29;14(11):1333-42. Epub 2014 Apr 29.

Division of Functional Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201300320DOI Listing
June 2014

PI3K/AKT pathway activation in bladder carcinogenesis.

Int J Cancer 2014 Apr 24;134(8):1776-84. Epub 2013 Oct 24.

APHP, Groupe Hospitalier Henri Mondor, Département de Pathologie, 51 avenue du Mal-de-Lattre-de-Tassigny, 94010, Créteil, France; INSERM, U955, Institut Mondor de Recherche Biomédicale, 94010, Créteil, France; Université Paris-Est Créteil, 94010, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28518DOI Listing
April 2014

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.

Eur Urol 2014 Jan 9;65(1):154-61. Epub 2012 Jun 9.

INSERM U955 Equipe 7, Departments of Urology and Pathology, CHU Henri Mondor, APHP, Créteil, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2012.05.049DOI Listing
January 2014

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance.

Urol Oncol 2013 Oct 31;31(7):1060-6. Epub 2012 Jan 31.

INSERM U955 eq07 Departments of Urology and Pathology, APHP, CHU Henri Mondor, Créteil, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2011.12.018DOI Listing
October 2013

Patient selection and pathological outcomes using currently available active surveillance criteria.

BJU Int 2013 Aug 7;112(4):471-7. Epub 2013 Jun 7.

Department of Urology, APHP, CHU Henri Mondor, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12154DOI Listing
August 2013

External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.

Ann Surg Oncol 2013 Apr 4;20(4):1389-94. Epub 2012 Dec 4.

Department of Urology, Henri Mondor Hospital, University Paris Est Créteil (Paris 12), Creteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-012-2753-0DOI Listing
April 2013

SMARCB1/INI1 inactivation in renal medullary carcinoma.

Histopathology 2012 Sep 11;61(3):428-35. Epub 2012 Jun 11.

AP-HP, Département de Pathologie, Hôpital H. Mondor - A. Chenevier, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2012.04228.xDOI Listing
September 2012

Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.

Urology 2012 Sep;80(3):576-84

Institut National de la Sante et de la Recherche Medicale Unit 955 EQ7, Department of Urology, APHP, CHU Henri Mondor, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.04.066DOI Listing
September 2012

[Diagnostic issues of prostate biopsies. Case 7. Gleason grade 4 adenocarcinoma, with ill-defined glands and poorly formed glandular lumina].

Authors:
Yves Allory

Ann Pathol 2012 Apr 27;32(2):137-40. Epub 2012 Mar 27.

Département de pathologie, hôpital Henri-Mondor, AP-HP, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2012.02.008DOI Listing
April 2012

[Diagnostic issues of prostate biopsies. Case 8. How to report the different grades observed on prostate biopsies?].

Authors:
Yves Allory

Ann Pathol 2012 Apr 27;32(2):141-4. Epub 2012 Mar 27.

Département de pathologie, hôpital Henri Mondor, AP-HP, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2012.02.009DOI Listing
April 2012

Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors.

World J Urol 2011 Oct 24;29(5):671-6. Epub 2010 Nov 24.

Department of Urology and Pathology, INSERM U955 Eq07, CHU Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-010-0620-9DOI Listing
October 2011

Kidney cancer pathology in the new context of targeted therapy.

Pathobiology 2011 14;78(2):90-8. Epub 2011 Jun 14.

INSERM U955, Team 7 'Translational research in genitourinary oncogenesis', Henri Mondor Hospital, AP-HP, Créteil, France. yves.allory @ hmn.aphp.fr

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000315543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361895PMC
October 2011

Toward a standardized urine proteome analysis methodology.

Proteomics 2011 Mar 16;11(6):1160-71. Epub 2011 Feb 16.

DECanBio consortium, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201000566DOI Listing
March 2011

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis.

Genome Biol 2010 22;11(7):R76. Epub 2010 Jul 22.

INSERM, UMR-S 973, MTi, Université Paris Diderot - Paris 7, 35 rue Hélène Brion, 75205 Paris Cedex 13, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gb-2010-11-7-r76DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926787PMC
December 2010

Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

Cancer Res 2010 Nov 2;70(22):9253-64. Epub 2010 Nov 2.

INSERM, Unité 955; Université Paris-Est, Faculté de Médecine; AP-HP, Groupe Henri Mondor-Albert Chenevier, Service d'Urologie, Département de Pathologie et Centre d'Investigations Biomédicales, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290526PMC
November 2010

The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.

J Urol 2010 Jun;183(6):2161-4

Institut National en Santé et Recherche Médicale U955 EQ7, Departments of Urology and Pathology Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Universitaire Henri Mondor, 94010 Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.02.026DOI Listing
June 2010